NYSE$CVSA
Covista Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Announced fiscal third quarter 2022 results, with a strengthened balance sheet and capital allocation driving increased FY’22 EPS guidance.
Adtalem Global Education reported a revenue increase of 58.8% to $365.6 million compared to the prior year, driven by the acquisition of Walden. Diluted earnings per share was $7.09, and net income attributable to Adtalem was $349.8 million, primarily due to the gain on the sale of the Financial Services segment.
- Completed the divestiture of the Financial Services segment for $1 billion.
- Utilized $770 million from the divestiture to pay down debt, reducing it by 46.7%.
- Repurchased 4.7 million shares for $150 million in an accelerated share buyback program.
- Achieved high first-time residency attainment rates at the medical schools.
Headline financials
Revenue & EPS history
Adtalem · Revenue · Quarterly
$366M
Revenue by segment
Adtalem · $366M total across 3 segments · Q3 2022
- Chamberlain$143M—39.0%
- Walden$139M—38.0%
- Medical and Veterinary$84M—23.0%
Forward guidance
Adtalem reiterated its full fiscal year 2022 guidance for adjusted revenue, excluding special items, to be within the range of $1,350 million and $1,390 million, and increased the fiscal year 2022 guidance for adjusted diluted earnings per share from continuing operations, excluding special items, in excess of 8% to a range of $3.15 to $3.35.
Tailwinds
- Use of $770 million of net proceeds from the sale of the Financial Services segment towards repayment of debt, thereby reducing interest expense.
- Accelerated share repurchase program for $150 million of the company’s common stock, which is expected to be completed by the second quarter of fiscal 2023, reducing outstanding shares.
- Revenue excluding special items expected between $1,350 million and $1,390 million.
- Adjusted diluted EPS from continuing operations excluding special items expected between $3.15 and $3.35.
- Focus on healthcare education and talent provision.
Headwinds
- Potential impacts of the COVID-19 pandemic.
- Uncertainties related to forward-looking statements.
- Risk factors described in the company's filings with the SEC.
- Possible business or asset acquisitions or dispositions.
- Additional charges to special items or additional special items not currently identified.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
-0.7%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+0.7%
Avg return
30 days after
43%
29 / 67 earnings
Positive
+22.8%
Q1 2013
Best reaction
-33.2%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +13.2% | +10.2% | +8.0% | |
| Q2 2026 | -7.8% | -14.2% | -15.5% | |
| Q1 2026 | -33.2% | -31.2% | -34.7% | |
| Q3 2025 | +16.4% | +11.9% | +10.7% | |
| Q2 2025 | +4.6% | +7.5% | -0.1% | |
| Q1 2025 | +12.0% | +8.7% | +23.8% | |
| Q4 2024 | -7.3% | -2.1% | -2.2% | |
| Q3 2024 | +18.9% | +24.8% | +27.5% | |
| Q2 2024 | -13.9% | -17.5% | -15.6% | |
| Q1 2024 | +12.5% | +16.6% | +29.4% | |
| Q4 2023 | -1.1% | -4.0% | -0.8% | |
| Q3 2023 | +4.5% | +2.0% | +2.4% | |
| Q2 2023 | +13.7% | +3.1% | +2.2% | |
| Q1 2023 | +2.4% | +6.9% | -2.1% | |
| Q4 2022 | -3.1% | -2.6% | -2.8% | |
| Q3 2022 | +6.4% | +10.9% | +17.5% | |
| Q2 2022 | -12.7% | -16.0% | -15.2% | |
| Q1 2022 | -12.9% | -6.0% | -16.6% | |
| Q4 2021 | +1.3% | +0.3% | +11.8% | |
| Q3 2021 | -6.9% | -8.3% | -1.3% | |
| Q2 2021 | +0.1% | +0.9% | -2.8% | |
| Q1 2021 | +3.7% | +11.0% | +16.6% | |
| Q4 2020 | -4.4% | -6.5% | -25.9% | |
| Q3 2020 | +3.7% | +9.8% | +11.5% | |
| Q2 2020 | +3.1% | -3.0% | -14.9% | |
| Q1 2020 | -19.2% | -16.8% | -7.8% | |
| Q4 2019 | -12.5% | -14.6% | -20.9% | |
| Q3 2019 | -7.6% | -9.0% | -11.4% | |
| Q2 2019 | -3.3% | -3.6% | -4.1% | |
| Q1 2019 | +4.3% | +10.7% | +14.0% | |
| Q4 2018 | -15.8% | -13.5% | -20.0% | |
| Q3 2018 | -5.7% | -3.0% | +1.4% | |
| Q2 2018 | +7.1% | +3.7% | +12.3% | |
| Q1 2018 | -2.7% | +1.1% | +9.7% | |
| Q4 2017 | +4.3% | +4.0% | +8.1% | |
| Q3 2017 | -0.8% | +5.0% | +0.5% | |
| Q2 2017 | -0.5% | -3.0% | +0.2% | |
| Q1 2017 | +1.8% | +1.5% | +31.5% | |
| Q4 2016 | +17.7% | +11.8% | +4.3% | |
| Q3 2016 | +17.3% | — | — | |
| Q2 2016 | -14.2% | — | — | |
| Q1 2016 | -2.3% | — | — | |
| Q4 2015 | -7.7% | — | — | |
| Q3 2015 | -15.9% | — | — | |
| Q2 2015 | -17.9% | — | — | |
| Q1 2015 | +0.8% | — | — | |
| Q4 2014 | -3.2% | — | — | |
| Q3 2014 | +13.0% | — | — | |
| Q2 2014 | -2.6% | — | — | |
| Q1 2014 | +6.2% | — | — | |
| Q4 2013 | -9.5% | — | — | |
| Q3 2013 | -17.6% | — | — | |
| Q2 2013 | +19.1% | — | — | |
| Q1 2013 | +22.8% | — | — | |
| Q4 2009 | -2.2% | — | — | |
| Q4 2012 | -2.3% | — | — | |
| Q3 2012 | -0.4% | — | — | |
| Q2 2012 | -8.5% | — | — | |
| Q1 2012 | -0.8% | — | — | |
| Q4 2011 | +4.7% | — | — | |
| Q3 2011 | -1.4% | — | — | |
| Q3 2010 | -1.4% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q4 2010 | -1.1% | — | — | |
| Q1 2010 | -1.1% | — | — | |
| Q1 2011 | -1.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro